A controlled substance is a drug or chemical whose manufacture, possession, and use are regulated by the government. The regulation takes into account factors such as medical use, potential for abuse, and safety or dependence liability. Under the Controlled Substances Act (CSA), substances are classified into five schedules based on these criteria. Controlled substances require special prescriptions and strict protocols for prescription transmission.

However, increasingly abundant scientific research and evolving public attitudes have led to recommendations for its reclassification. It should be moved to Schedule III, advocates argue. They recognize its lower abuse potential and acknowledged therapeutical benefits. The final decision lies with the Drug Enforcement Administration (DEA).

The CSA, enacted in 1970 during President Richard Nixon‘s administration, serves as the cornerstone of federal drug control policy in the United States. It was designed to fulfill international treaty requirements and categorizes drugs into five schedules, taking into account factors like potential for abuse and medical utility. Notably, it governs narcotics, stimulants, depressants, hallucinogens, and other chemicals.

However, it’s crucial to note that the CSA‘s implementation coincided with the launch of the War on Drugs in 1971, an initiative that ostensibly aimed to create a safer America but, in practice, disproportionately targeted minority communities. Policing practices within this context concealed underlying racial biases, leading to decades of unjust imprisonment for people of color.

Starting Black History Month, it is worth noting that the ongoing discussion surrounding cannabis legalization highlights the repercussions of the War on Drugs, particularly its role in perpetuating structural racism.  While cannabis remains a Schedule I substance, the debate continues, and the legacy of the War on Drugs underscores the imperative to address racial disparities in drug policy and beyond.